XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023   26,597,000      
Stockholders' equity, beginning balance at Dec. 31, 2023 $ 88,103 $ 27 $ 702,969 $ (797) $ (614,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   53,000      
Issuance of common stock from exercises of options and employee stock purchase plan 811   811    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,014,000      
Net share settlement of restricted stock units (in shares)   (347,000)      
Net share settlement of restricted stock units (7,504)   (7,504)    
Stock-based compensation 10,131   10,131    
Comprehensive gain (loss), net 173     173  
Net loss (43,936)       (43,936)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2024   27,317,000      
Stockholders' equity, ending balance at Mar. 31, 2024 47,778 $ 27 706,407 (624) (658,032)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023   26,597,000      
Stockholders' equity, beginning balance at Dec. 31, 2023 88,103 $ 27 702,969 (797) (614,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (90,596)        
Stockholders' equity, ending balance (in shares) at Jun. 30, 2024   27,434,000      
Stockholders' equity, ending balance at Jun. 30, 2024 9,879 $ 27 714,959 (415) (704,692)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2024   27,317,000      
Stockholders' equity, beginning balance at Mar. 31, 2024 47,778 $ 27 706,407 (624) (658,032)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   75,000      
Issuance of common stock from exercises of options and employee stock purchase plan 1,008   1,008    
Issuance of common stock upon vesting of restricted stock units (in shares)   42,000      
Stock-based compensation 7,544   7,544    
Comprehensive gain (loss), net 209     209  
Net loss (46,660)       (46,660)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2024   27,434,000      
Stockholders' equity, ending balance at Jun. 30, 2024 $ 9,879 $ 27 714,959 (415) (704,692)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024 30,473,000 30,473,000      
Stockholders' equity, beginning balance at Dec. 31, 2024 $ 70,868 $ 30 829,860 305 (759,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   44,000      
Issuance of common stock from exercises of options and employee stock purchase plan 290   290    
Issuance of common stock upon vesting of restricted stock units (in shares)   262,000      
Net share settlement of restricted stock units (in shares)   (98,000)      
Net share settlement of restricted stock units (1,451)   (1,451)    
Repurchases and retirements of common stock (in shares)   (293,000)      
Repurchases and retirements of common stock (5,383)   (5,383)    
Stock-based compensation 9,170   9,170    
Comprehensive gain (loss), net (144)     (144)  
Net loss (39,329)       (39,329)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2025   30,388,000      
Stockholders' equity, ending balance at Mar. 31, 2025 $ 34,021 $ 30 832,486 161 (798,656)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024 30,473,000 30,473,000      
Stockholders' equity, beginning balance at Dec. 31, 2024 $ 70,868 $ 30 829,860 305 (759,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (77,959)        
Stockholders' equity, ending balance (in shares) at Jun. 30, 2025 27,972,997 27,973,000      
Stockholders' equity, ending balance at Jun. 30, 2025 $ (44,733) $ 28 792,531 (6) (837,286)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2025   30,388,000      
Stockholders' equity, beginning balance at Mar. 31, 2025 34,021 $ 30 832,486 161 (798,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   84,000      
Issuance of common stock from exercises of options and employee stock purchase plan 1,423   1,423    
Issuance of common stock upon vesting of restricted stock units (in shares)   62,000      
Repurchases and retirements of common stock (in shares)   (2,561,000)      
Repurchases and retirements of common stock (50,619) $ (2) (50,617)    
Stock-based compensation 9,239   9,239    
Comprehensive gain (loss), net (167)     (167)  
Net loss $ (38,630)       (38,630)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2025 27,972,997 27,973,000      
Stockholders' equity, ending balance at Jun. 30, 2025 $ (44,733) $ 28 $ 792,531 $ (6) $ (837,286)